Creo Medical Group PLC (CREO) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.256x

Based on the latest financial reports, Creo Medical Group PLC (CREO) has a cash flow conversion efficiency ratio of 0.256x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX15.60 Million ≈ $1.90K USD) by net assets (GBX60.90 Million ≈ $7.41K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Creo Medical Group PLC - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Creo Medical Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Creo Medical Group PLC (CREO) total liabilities for a breakdown of total debt and financial obligations.

Creo Medical Group PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Creo Medical Group PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Midsona AB (publ) ST:MSON-A	0.048x
R.E.A. Holdings plc LSE:RE	0.017x
Jersey Electricity plc LSE:JEL	0.039x
Tian Ruixiang Holdings Ltd NASDAQ:TIRX	-0.083x
CERo Therapeutics Holdings, Inc. Common Stock NASDAQ:CERO	0.705x
Newtopia Inc V:NEWU	0.060x
Schroder British Opportunities Trus LSE:SBO	N/A
Antelope Enterprise Holdings Ltd NASDAQ:AEHL	0.191x

Annual Cash Flow Conversion Efficiency for Creo Medical Group PLC (2014–2024)

The table below shows the annual cash flow conversion efficiency of Creo Medical Group PLC from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Creo Medical Group PLC worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX42.40 Million ≈ $5.16K	GBX-22.20 Million ≈ $-2.70K	-0.524x	-44.96%
2023-12-31	GBX59.80 Million ≈ $7.28K	GBX-21.60 Million ≈ $-2.63K	-0.361x	+28.59%
2022-12-31	GBX49.40 Million ≈ $6.01K	GBX-24.99 Million ≈ $-3.04K	-0.506x	-42.74%
2021-12-31	GBX73.32 Million ≈ $8.92K	GBX-25.98 Million ≈ $-3.16K	-0.354x	-38.36%
2020-12-31	GBX62.81 Million ≈ $7.64K	GBX-16.09 Million ≈ $-1.96K	-0.256x	-83.44%
2019-12-31	GBX82.66 Million ≈ $10.06K	GBX-11.54 Million ≈ $-1.40K	-0.140x	+53.07%
2018-12-31	GBX47.71 Million ≈ $5.81K	GBX-14.20 Million ≈ $-1.73K	-0.298x	+68.83%
2018-06-30	GBX7.33 Million ≈ $891.73	GBX-7.00 Million ≈ $-851.17	-0.955x	-102.27%
2017-06-30	GBX14.65 Million ≈ $1.78K	GBX-6.91 Million ≈ $-841.33	-0.472x	+53.13%
2016-06-30	GBX1.63 Million ≈ $198.22	GBX-1.64 Million ≈ $-199.58	-1.007x	-3.79%
2016-02-29	GBX3.22 Million ≈ $392.03	GBX-3.13 Million ≈ $-380.30	-0.970x	+68.09%
2015-02-28	GBX748.41K ≈ $91.06	GBX-2.27 Million ≈ $-276.80	-3.040x	-206.94%
2014-02-28	GBX1.37 Million ≈ $167.26	GBX-1.36 Million ≈ $-165.64	-0.990x	--

About Creo Medical Group PLC

LSE:CREO UK Medical Devices

Market Cap

$633.60K

GBX5.21 Billion GBX

Market Cap Rank

#30447 Global

#871 in UK

Share Price

GBX12.63

Change (1 day)

-2.88%

52-Week Range

GBX9.90 - GBX17.75

All Time High

GBX243.00